{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:47:09Z","timestamp":1791172029732,"version":"4.1.0"},"reference-count":39,"publisher":"American Association for Cancer Research (AACR)","issue":"15","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Uterine leiomyomata, or fibroids, are benign tumors of the uterine myometrium that significantly affect up to 30% of reproductive-age women. Despite being the primary cause of hysterectomy in the United States, accounting for up to 200,000 procedures annually, the etiology of leiomyoma remains largely unknown. As a basis for understanding leiomyoma pathogenesis and identifying targets for pharmacotherapy, we conducted transcriptional profiling of leiomyoma and unaffected myometrium from humans and Eker rats, the best characterized preclinical model of leiomyomata. A global comparison of mRNA from leiomyoma versus myometrium in human and rat identified a highly significant overlap of dysregulated gene expression in leiomyomata. An unbiased pathway analysis using a method of gene-set enrichment based on the sigPathway algorithm detected the mammalian target of rapamycin (mTOR) pathway as one of the most highly up-regulated pathways in both human and rat tumors. To validate this pathway as a therapeutic target for uterine leiomyomata, preclinical studies were conducted in Eker rats. These rats develop uterine leiomyomata as a consequence of loss of Tsc2 function and up-regulation of mTOR signaling. Inhibition of mTOR in female Eker rats with the rapamycin analogue WAY-129327 for 2 weeks decreased mTOR signaling and cell proliferation in tumors, and treatment for 4 months significantly decreased tumor incidence, multiplicity, and size. These results identify dysregulated mTOR signaling as a component of leiomyoma etiology across species and directly show the dependence of uterine leiomyomata with activated mTOR on this signaling pathway for growth. [Cancer Res 2009;69(15):6171\u20138]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-4471","type":"journal-article","created":{"date-parts":[[2009,7,21]],"date-time":"2009-07-21T22:24:10Z","timestamp":1248215050000},"page":"6171-6178","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Comparison of Human and Rat Uterine Leiomyomata: Identification of a Dysregulated Mammalian Target of Rapamycin Pathway"],"prefix":"10.1158","volume":"69","author":[{"given":"Judy S.","family":"Crabtree","sequence":"first","affiliation":[{"name":"1Endocrinology & Reproductive Disorders Division, Women's Health and Musculoskeletal Biology, Wyeth Research, Collegeville, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Jelinsky","sequence":"additional","affiliation":[{"name":"2Biological Technologies and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Harris","sequence":"additional","affiliation":[{"name":"1Endocrinology & Reproductive Disorders Division, Women's Health and Musculoskeletal Biology, Wyeth Research, Collegeville, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung E.","family":"Choe","sequence":"additional","affiliation":[{"name":"2Biological Technologies and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monette M.","family":"Cotreau","sequence":"additional","affiliation":[{"name":"3Translational Research, Wyeth Research, Cambridge, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Kimberland","sequence":"additional","affiliation":[{"name":"1Endocrinology & Reproductive Disorders Division, Women's Health and Musculoskeletal Biology, Wyeth Research, Collegeville, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Wilson","sequence":"additional","affiliation":[{"name":"2Biological Technologies and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Saraf","sequence":"additional","affiliation":[{"name":"2Biological Technologies and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"2Biological Technologies and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne S.","family":"McCampbell","sequence":"additional","affiliation":[{"name":"4Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuvanesh","family":"Dave","sequence":"additional","affiliation":[{"name":"5Department of Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Smithville, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell R.","family":"Broaddus","sequence":"additional","affiliation":[{"name":"4Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene L.","family":"Brown","sequence":"additional","affiliation":[{"name":"2Biological Technologies and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Kao","sequence":"additional","affiliation":[{"name":"6Chemical and Screening Sciences, Wyeth Research, Pearl River, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerauld S.","family":"Skotnicki","sequence":"additional","affiliation":[{"name":"6Chemical and Screening Sciences, Wyeth Research, Pearl River, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magid","family":"Abou-Gharbia","sequence":"additional","affiliation":[{"name":"6Chemical and Screening Sciences, Wyeth Research, Pearl River, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Winneker","sequence":"additional","affiliation":[{"name":"1Endocrinology & Reproductive Disorders Division, Women's Health and Musculoskeletal Biology, Wyeth Research, Collegeville, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Walker","sequence":"additional","affiliation":[{"name":"5Department of Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Smithville, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,7,29]]},"reference":[{"key":"2022061701350633300_B1","doi-asserted-by":"crossref","unstructured":"Cramer S, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol\u20081990; 94: 435\u20138.","DOI":"10.1093\/ajcp\/94.4.435"},{"key":"2022061701350633300_B2","doi-asserted-by":"crossref","unstructured":"Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science\u20082005; 308: 1589\u201392.","DOI":"10.1126\/science.1112063"},{"key":"2022061701350633300_B3","doi-asserted-by":"crossref","unstructured":"Arslan AA, Gold LI, Mittal K, et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod\u20082005; 20: 852\u201363.","DOI":"10.1093\/humrep\/deh698"},{"key":"2022061701350633300_B4","doi-asserted-by":"crossref","unstructured":"Newbold RR, Moore AB, Dixon D. Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES). Toxicol Pathol\u20082002; 30: 611\u20136.","DOI":"10.1080\/01926230290105839"},{"key":"2022061701350633300_B5","doi-asserted-by":"crossref","unstructured":"Politi K, Szabolcs M, Fisher P, Kljuic A, Ludwig T, Efstratiadis A. A mouse model of uterine leiomyosarcoma. Am J Pathol\u20082004; 164: 325\u201336.","DOI":"10.1016\/S0002-9440(10)63122-7"},{"key":"2022061701350633300_B6","doi-asserted-by":"crossref","unstructured":"Romagnolo B, Molina T, Leroy G, et al. Estradiol-dependent uterine leiomyomas in transgenic mice. J Clin Invest\u20081996; 98: 777\u201384.","DOI":"10.1172\/JCI118850"},{"key":"2022061701350633300_B7","doi-asserted-by":"crossref","unstructured":"Walker CL, Hunter D, Everitt JI. Uterine leiomyoma in the Eker rat: a unique model for important diseases of women. Genes Chromosomes Cancer\u20082003; 38: 349\u201356.","DOI":"10.1002\/gcc.10281"},{"key":"2022061701350633300_B8","doi-asserted-by":"crossref","unstructured":"Porter KB, Tsibris JC, Porter GW, et al. Effects of raloxifene in a guinea pig model for leiomyomas. Am J Obstet Gynecol\u20081998; 179: 1283\u20137.","DOI":"10.1016\/S0002-9378(98)70148-6"},{"key":"2022061701350633300_B9","unstructured":"Porter KB, Tsibris JC, Porter GW, O'Brien WF, Spellacy WN. Use of endoscopic and ultrasound techniques in the guinea pig leiomyoma model. Lab Anim Sci\u20081997; 47: 537\u20139."},{"key":"2022061701350633300_B10","unstructured":"Tsibris JC, Porter KB, Jazayeri A, et al. Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor \u03b3, retinoid X receptor \u03b1, and all-trans retinoic acid than myometrium. Cancer Res\u20081999; 59: 5737\u201344."},{"key":"2022061701350633300_B11","doi-asserted-by":"crossref","unstructured":"Mozzachio K, Linder K, Dixon D. Uterine smooth muscle tumors in potbellied pigs (Sus scrofa) resemble human fibroids: a potential animal model. Toxicol Pathol\u20082004; 32: 402\u20137.","DOI":"10.1080\/01926230490440880"},{"key":"2022061701350633300_B12","doi-asserted-by":"crossref","unstructured":"Cook JD, Walker CL. The Eker rat: establishing a genetic paradigm linking renal cell carcinoma and uterine leiomyoma. Curr Mol Med\u20082004; 4: 813\u201324.","DOI":"10.2174\/1566524043359656"},{"key":"2022061701350633300_B13","doi-asserted-by":"crossref","unstructured":"Eker R, Mossige J. A dominant gene for renal adenomas in the rat. Nature\u20081961; 189: 856\u20139.","DOI":"10.1038\/189858b0"},{"key":"2022061701350633300_B14","doi-asserted-by":"crossref","unstructured":"Kobayashi T, Hirayama Y, Kobayashi E, Kubo Y, Hino O. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet\u20081995; 9: 70\u20134.","DOI":"10.1038\/ng0195-70"},{"key":"2022061701350633300_B15","doi-asserted-by":"crossref","unstructured":"Yeung RS, Buetow KH, Testa JR, Knudson AG, Jr. Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10. Proc Natl Acad Sci U S A\u20081993; 90: 8038\u201342.","DOI":"10.1073\/pnas.90.17.8038"},{"key":"2022061701350633300_B16","doi-asserted-by":"crossref","unstructured":"Chiang GG, Abraham RT. Targeting the mTOR signaling network in cancer. Trends Mol Med\u20082007; 13: 433\u201342.","DOI":"10.1016\/j.molmed.2007.08.001"},{"key":"2022061701350633300_B17","doi-asserted-by":"crossref","unstructured":"Tsang CK, Qi H, Liu LF, Zheng XS. Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov Today\u20082006; 12: 112\u201324.","DOI":"10.1016\/j.drudis.2006.12.008"},{"key":"2022061701350633300_B18","doi-asserted-by":"crossref","unstructured":"Cotreau MM, Chennathukuzhi VM, Harris HA, et al. A study of 17\u03b2-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy. Maturitas\u20082007; 58: 366\u201376.","DOI":"10.1016\/j.maturitas.2007.09.009"},{"key":"2022061701350633300_B19","doi-asserted-by":"crossref","unstructured":"Baldi P, Long AD. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics\u20082001; 17: 509\u201319.","DOI":"10.1093\/bioinformatics\/17.6.509"},{"key":"2022061701350633300_B20","doi-asserted-by":"crossref","unstructured":"Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor R. New York: Springer; 2005. p. 397\u2013420.","DOI":"10.1007\/0-387-29362-0_23"},{"key":"2022061701350633300_B21","doi-asserted-by":"crossref","unstructured":"Sayers EW, Barrett T, Benson DA, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res\u20082009; 37: D5\u201315.","DOI":"10.1093\/nar\/gkn741"},{"key":"2022061701350633300_B22","doi-asserted-by":"crossref","unstructured":"Tian L, Greenberg SA, Kong SW, Altschuler J, Kohane IS, Park PJ. Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci U S A\u20082005; 102: 13544\u20139.","DOI":"10.1073\/pnas.0506577102"},{"key":"2022061701350633300_B23","doi-asserted-by":"crossref","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A\u20082005; 102: 15545\u201350.","DOI":"10.1073\/pnas.0506580102"},{"key":"2022061701350633300_B24","unstructured":"Howe SR, Gottardis MM, Everitt JI, Goldsworthy TL, Wolf DC, Walker CL. Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. Am J Pathol\u20081995; 146: 1568\u201379."},{"key":"2022061701350633300_B25","doi-asserted-by":"crossref","unstructured":"Peng T, Golub TR, Sabatini DM. The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol Cell Biol\u20082002; 22: 5575\u201384.","DOI":"10.1128\/MCB.22.15.5575-5584.2002"},{"key":"2022061701350633300_B26","doi-asserted-by":"crossref","unstructured":"Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1\u03b1 transcriptional complex. Nature\u20082007; 450: 736\u201340.","DOI":"10.1038\/nature06322"},{"key":"2022061701350633300_B27","doi-asserted-by":"crossref","unstructured":"McMahon LP, Choi KM, Lin T-A, Abraham RT, Lawrence JC, Jr. The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin. Mol Cell Biol\u20082002; 22: 7428\u201338.","DOI":"10.1128\/MCB.22.21.7428-7438.2002"},{"key":"2022061701350633300_B28","doi-asserted-by":"crossref","unstructured":"Wang X, Beugnet A, Murakami M, Yamanaka S, Proud CG. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol Cell Biol\u20082005; 25: 2558\u201372.","DOI":"10.1128\/MCB.25.7.2558-2572.2005"},{"key":"2022061701350633300_B29","doi-asserted-by":"crossref","unstructured":"Schwartz SM, Marshall LM, Baird DD. Epidemiological contributions to understanding the etiology of uterine leiomyomata. Environ Health Perspect\u20082000; 108: 821\u20137.","DOI":"10.1289\/ehp.00108s5821"},{"key":"2022061701350633300_B30","doi-asserted-by":"crossref","unstructured":"Lobel MK, Somasundaram P, Morton CC. The genetic heterogeneity of uterine leiomyomata. Obstet Gynecol Clin North Am\u20082006; 33: 13\u201339.","DOI":"10.1016\/j.ogc.2005.12.006"},{"key":"2022061701350633300_B31","doi-asserted-by":"crossref","unstructured":"Chwalisz K, Larsen L, Mattia-Goldberg C, Edmonds A, Elger W, Winkel C. A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata. Fertil Steril\u20082007; 87: 1399\u2013412.","DOI":"10.1016\/j.fertnstert.2006.11.094"},{"key":"2022061701350633300_B32","doi-asserted-by":"crossref","unstructured":"Geiser A, Hummel CW, Draper MW, et al. A new selective estrogen receptor modulator with potent uterine antagonist activity in bone, and minimal ovarian stimulation. Endocrinology\u20082005; 146: 4524\u201335.","DOI":"10.1210\/en.2005-0024"},{"key":"2022061701350633300_B33","doi-asserted-by":"crossref","unstructured":"Skubitz KM, Skubitz AP. Differential gene expression in uterine leiomyoma. J Lab Clin Med\u20082003; 141: 297\u2013308.","DOI":"10.1016\/S0022-2143(03)00007-6"},{"key":"2022061701350633300_B34","doi-asserted-by":"crossref","unstructured":"Jelinsky SA, Choe SE, Crabtree JS, et al. Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal women. BMC Med Genomics\u20082008; 1: 27\u201338.","DOI":"10.1186\/1755-8794-1-27"},{"key":"2022061701350633300_B35","doi-asserted-by":"crossref","unstructured":"McCarroll SA, Murphy CT, Zou S, et al. Comparing genomic expression patterns across species identifies shared transcriptional profile in aging. Nat Genet\u20082004; 36: 197\u2013204.","DOI":"10.1038\/ng1291"},{"key":"2022061701350633300_B36","doi-asserted-by":"crossref","unstructured":"Kenerson H, Dundon TA, Yeung RS. Effects of rapamycin in the Eker rat model of tuberous sclerosis complex. Pediatr Res\u20082005; 57: 67\u201375.","DOI":"10.1203\/01.PDR.0000147727.78571.07"},{"key":"2022061701350633300_B37","doi-asserted-by":"crossref","unstructured":"Suzuki T, Kopia G, Hayashi S-I, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation\u20082001; 104: 1188\u201393.","DOI":"10.1161\/hc3601.093987"},{"key":"2022061701350633300_B38","doi-asserted-by":"crossref","unstructured":"Chang SB, Miron P, Miron A, Iglehart JD. Rapamycin inhibits proliferation of estrogen-receptor positive breast cancer cells. J Surg Res\u20082007; 138: 37\u201344.","DOI":"10.1016\/j.jss.2006.07.003"},{"key":"2022061701350633300_B39","doi-asserted-by":"crossref","unstructured":"Yin XJ, Wang G, Khan-Dawood FS. Requirements of phosphatidylinositol-3 kinase and mammalian target of rapamycin for estrogen-induced proliferation in uterine leiomyoma- and myometrium-derived cell lines. Am J Obstet Gynecol\u20082007; 196: 176e1\u20135.","DOI":"10.1016\/j.ajog.2006.09.037"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/15\/6171\/2867628\/6171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/15\/6171\/2867628\/6171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:37:32Z","timestamp":1655437052000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/15\/6171\/549928\/Comparison-of-Human-and-Rat-Uterine-Leiomyomata"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,29]]},"references-count":39,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2009,7,29]]},"published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-4471","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22377996","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378008","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377999","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377996.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377993.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378002.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378011","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378002","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377999.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377993","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378005","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378011.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378008.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22378005.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6498783.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498783","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,29]]}}}